Latest News

Add to Favorites Subscribe Share
newswise-fb-share-
Newswise: While Promoting Diseases Like Cancer, These Enzymes Also Cannibalize Each Other
  • Embargo expired:
    20-Jan-2020 3:00 PM EST

While Promoting Diseases Like Cancer, These Enzymes Also Cannibalize Each Other

Georgia Institute of Technology

In diseases like cancer, atherosclerosis, and sickle cell anemia, cathepsins promote their propagation. Drug trials to inhibit these enzymes have failed due to baffling side effects. Now a new study examines cathepsins in systems to remove some of the bafflement.

Channels: All Journal News, Grant Funded News, Blood, Cancer, Clinical Trials, Pharmaceuticals,

Released:
17-Jan-2020 10:05 AM EST
Open in New Tab
Comment
CUIMC_RGB.jpg
  • Embargo expired:
    20-Jan-2020 2:30 PM EST

An Estimated 2 Million People With Heart Disease Have Used Marijuana, Finds Study

Columbia University Irving Medical Center

A new study estimates that more than 2 million Americans with heart disease have used marijuana, but the cardiovascular effects of the drug are not fully understood.

Channels: Cardiovascular Health, Heart Disease, Marijuana, Smoking, All Journal News,

Released:
17-Jan-2020 4:25 PM EST
Open in New Tab
Comment
Expert Pitch
mmc-logo.gif

Certain liver cells may help prevent organ rejection after transplant and other conditions, study finds

Mayo Clinic

Mesenchymal stromal cells from fat tissue and bone marrow are widely used in therapeutic trials for their anti-inflammatory qualities, but new Mayo Clinic research finds that liver cells may be of greater value. The study, published in Liver Transplantation, finds that liver mesenchymal stromal cells have immunoregulatory qualities that make them more effective than similar cells derived from adipose, or fat, tissue and bone marrow.

Channels: Immunology, Kidney Disease, Liver Disease, Transplantation,

Released:
20-Jan-2020 2:25 PM EST
Open in New Tab
Comment
Research Results
Newswise: First detailed electronic study of new nickelate superconductor finds 3D metallic state

First detailed electronic study of new nickelate superconductor finds 3D metallic state

SLAC National Accelerator Laboratory

It represents an entirely new type of ground state for transition metal oxides, and opens new directions for experiments and theoretical studies of how superconductivity arises and how it can be optimized in this system and possibly in other compounds.

Channels: Energy, Engineering, Materials Science, Physics, Travel and Transportation,

Released:
20-Jan-2020 11:50 AM EST
Open in New Tab
Comment
Research Results
Newswise: Dozens of potential anti-cancer drugs netted in massive screening study
  • Embargo expired:
    20-Jan-2020 11:00 AM EST

Dozens of potential anti-cancer drugs netted in massive screening study

Dana-Farber Cancer Institute

A variety of existing drugs for treating conditions such as diabetes, inflammation, alcohol abuse, and arthritis in dogs can also kill cancer cells in the lab, according to a study by scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.

Channels: All Journal News, Grant Funded News, Cancer, Clinical Trials, Pharmaceuticals, National Institutes of Health (NIH), Nature (journal),

Released:
19-Jan-2020 11:05 AM EST
Open in New Tab
Comment
Research Results
Newswise: Native Americans Did Not Make Large-Scale Changes to Environment Prior to European Contact
  • Embargo expired:
    20-Jan-2020 11:00 AM EST
Released:
17-Jan-2020 11:00 AM EST
Open in New Tab
Comment
Research Results

New Drug Prevents Liver Damage, Obesity and Glucose Intolerance in Mice on High-Fat Diet

Georgetown Lombardi Comprehensive Cancer Center

Mice given a new drug targeting a key gene involved in lipid and glucose metabolism could tolerate a high-fat diet regimen (composed of 60% fat from lard) without developing significant liver damage, becoming obese, or disrupting their body’s glucose balance.

Channels: Clinical Trials, Liver Disease, Obesity, Pharmaceuticals, Weight Loss, National Institutes of Health (NIH), Grant Funded News,

Released:
20-Jan-2020 10:50 AM EST
Open in New Tab
Comment
Research Results
Newswise: Select few cancer patients enroll in potentially life-extending clinical trials

Select few cancer patients enroll in potentially life-extending clinical trials

Penn State College of Medicine

Patient enrollment in clinical trials as the first course of treatment after cancer diagnosis is low, despite the fact that enrollment may increase life expectancy, according to researchers at Penn State.

Channels: Cancer, Clinical Trials, Healthcare, All Journal News,

Released:
20-Jan-2020 9:55 AM EST
Open in New Tab
Comment
Research Results
Newswise: Why aren’t advanced bladder cancers being treated?

Why aren’t advanced bladder cancers being treated?

UC Davis Comprehensive Cancer Center

Despite research showing that aggressive treatment with surgery, chemotherapy and radiation can extend the lives of and even cure patients with advanced bladder cancer, many don’t get it. The result, argues a team led by UC Davis Health urologists, is that the disease for many is still as deadly as it was 30 years ago.

Channels: Cancer, Healthcare, Surgery, All Journal News,

Released:
20-Jan-2020 9:00 AM EST
Open in New Tab
Comment
Research Results


0.88025